0001562180-22-000336.txt : 20220107
0001562180-22-000336.hdr.sgml : 20220107
20220107161647
ACCESSION NUMBER: 0001562180-22-000336
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220106
FILED AS OF DATE: 20220107
DATE AS OF CHANGE: 20220107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linetsky David
CENTRAL INDEX KEY: 0001776729
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38977
FILM NUMBER: 22518333
MAIL ADDRESS:
STREET 1: C/O PHREESIA, INC.
STREET 2: 432 PARK AVENUE S., 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phreesia, Inc.
CENTRAL INDEX KEY: 0001412408
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 434 FAYETTEVILLE ST.
STREET 2: SUITE 1400
CITY: RALEIGH
STATE: NC
ZIP: 27601
BUSINESS PHONE: 646-747-9959
MAIL ADDRESS:
STREET 1: 434 FAYETTEVILLE ST.
STREET 2: SUITE 1400
CITY: RALEIGH
STATE: NC
ZIP: 27601
FORMER COMPANY:
FORMER CONFORMED NAME: Phreesia Inc
DATE OF NAME CHANGE: 20070914
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-01-06
false
0001412408
Phreesia, Inc.
PHR
0001776729
Linetsky David
C/O PHREESIA, INC.
434 FAYETTEVILLE ST., SUITE 1400
RALEIGH
NC
27601
false
true
false
false
SVP, Life Sciences
Common Stock
2022-01-06
4
M
false
24314.00
4.71
A
164702.00
D
Common Stock
2022-01-06
4
M
false
948.00
4.71
A
165650.00
D
Common Stock
2022-01-06
4
M
false
5688.00
8.03
A
171338.00
D
Stock Options (Right to buy)
4.71
2022-01-06
4
M
false
24314.00
0.00
D
2028-08-06
Common Stock
24314.00
5689.00
D
Stock Options (Right to buy)
4.71
2022-01-06
4
M
false
948.00
0.00
D
2028-01-30
Common Stock
948.00
475.00
D
Stock Options (Right to buy)
8.03
2022-01-06
4
M
false
5688.00
0.00
D
2029-01-16
Common Stock
5688.00
5689.00
D
A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
25% of this option vested and became exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
25% of this option vested and became exercisable on January 17, 2020, with the remainder vesting in three (3) equal annual installments thereafter.
/s/ Allison Hoffman by Power of Attorney for David Linetsky
2022-01-07